Meeting
2015 Gastrointestinal Cancers Symposium
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management.
Authors
Michela Del Prete
Department of Medical Oncology, A.O. Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy
Michela Del Prete , Riccardo Giampieri , Fotios Loupakis , Tiziana Prochilo , Lisa Salvatore , Luca Faloppi , Maristella Bianconi , Alessandro Bittoni , Giuseppe Aprile , Alberto Zaniboni , Alfredo Falcone , Mario Scartozzi , Stefano Cascinu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 591)
DOI
10.1200/jco.2015.33.3_suppl.591
Abstract #
591
Poster Bd #
B35
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The predictive value of hematological markers in renal cell carcinoma.
First Author: Omar Al Ta'ani
Poster
2020 Gastrointestinal Cancers Symposium
Clinical impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) treated with regorafenib or trifluridine/tipiracil as later-line.
First Author: Hiromichi Nakajima
Poster
2020 Gastrointestinal Cancers Symposium
Association of neutrophil, platelet, and lymphocyte ratios with prognosis in metastatic pancreatic cancer.
First Author: Jessica Allen
Poster
2019 Gastrointestinal Cancers Symposium
Neutrophil/lymphocyte ratio (NLR) may predict prognostic factor with gemcitabine, cisplatin (GC) for patients with advanced biliary tract cancer.
First Author: Toru Otsuru